Back to Top

What’s New With the OHS?

Since 2010, the Ontario Health Study (OHS) has been working hard to build a platform for chronic disease research. Working together with the research community and Ontarians across the province we are now following the health of about 225,000 people and have collected more than 40,000 blood samples. We’re building a database of health information and a biobank so researchers can better understand the link between genetics, lifestyle and environment—and the role they play in our health.

In this section, you’ll find information about the various Study activities and upcoming initiatives.

Blood tubes in the laboratory centrifuge

CanPath Launches COVID-19 Initiative

Apr 23, 2020 // Study Updates

The Canadian Partnership for Tomorrow’s Health (CanPath) is launching the CanPath COVID-19 Initiative to support national COVID-19 related research activities. As Canada’s largest population health study, we have, over the past ten years, built a platform for population-level health research in Canada. We have worked alongside national and global partners to develop a COVID-19 specific questionnaire that

News Image

The Canadian Partnership for Tomorrow Project (CPTP) is now CanPath

Mar 17, 2020 // Study Updates

The Canadian Partnership for Tomorrow Project (CPTP) is now CanPath – the Canadian Partnership for Tomorrow’s Health. Together with our partners, CanPath is studying the biology, behaviours and environments of Canadians to learn more about the causes of chronic disease and cancer for a healthier Canada and world. Visit: canpath.ca.

News Image

What’s behind a cancer diagnosis in women under 50? Researcher looks to OHS data for clues

Feb 3, 2020 // Study Updates

A University of Calgary epidemiologist is using data from Ontario Health Study (OHS) participants to explore how environmental or lifestyle factors could be associated with breast cancer in younger women. Dr. Darren Brenner recently gained approval to study the de-identified data for female participants who were ages 35 to 50 and cancer-free at the time they

News Image